Business
MGC Pharma makes strong debut as London Stock Exchange’s first medicinal cannabis company – Stockhead
MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange Admission follows successful IPO for $11.6m from sophisticated and…
Link copied toclipboard
- MGC Pharma is the first medicinal cannabis company to be admitted to the London Stock Exchange
- Admission follows successful IPO for $11.6m from sophisticated and institutional investors
- Shares in MGC Pharma rise 60 per cent on LSE trading debut as listing was well received by investors
The share price of medicinal cannabis company MGC Pharmaceuticals (ASX:MXC) soared 60 per cent Tuesday on its first day of trading on the London Stock Exchange (LSE).
MGC Pharma is the first medicinal…
Continue Reading
-
General19 hours agoWondering about winter | The Spectator Australia
-
Noosa News17 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General17 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Business22 hours agoAre Domain Holdings shares undervalued?